
1. plos one. 2016 apr 29;11(4):e0153849. doi: 10.1371/journal.pone.0153849.
ecollection 2016.

regulation gag- env-specific cd8+ cell responses art-naïve
hiv-infected patients: potential implications individualized immunotherapy.

prebensen c(1)(2)(3), lind a(1), dyrhol-riise am(1)(2)(3), kvale d(1)(2)(3).

author information: 
(1)department infectious diseases, oslo university hospital, oslo, norway.
(2)institute clinical medicine, university oslo, oslo, norway.
(3)k.g. jebsen inflammation research centre, university oslo, oslo, norway.

strategies develop functional cure hiv infection likely require
boosting effector cell responses eliminate reactivated, latently infected
cells. recently explored assay assessing antigen-specific
regulation cell proliferation, related clinical progression 
untreated patients vaccine efficacy two trials therapeutic gag-based
vaccines. expand assay investigate regulation
mediated various inhibitory pathways. peripheral blood mononuclear cells 
26 asymptomatic hiv-infected, antiretroviral therapy-naïve patients were
stimulated gag env overlapping peptide panels 5 days. monoclonal
antibodies (mabs) blocking inhibitory mediators interleukin (il) 10, transforming
growth factor (tgf) β, programmed death ligand (pd-l) 1 herpes virus entry
mediator (hvem) added parallel cultures. functional cell regulation
(ftr) defined difference proliferation stimulated cultures 
with without blocking mabs. ftr detected 54% patients. blockade 
il-10/pd-l1 il10/tgf-β detected cases gag- env-associated ftr,
respectively. accordance previous findings, isolated env ftr was
associated higher plasma hiv rna lower cd4 counts, patients with
both gag env ftr also higher gag- env-specific proliferative cd8+ t
cell responses. association ftr frequencies activated
regulatory cells. conclusion, observed substantial heterogeneity ftr
between patients, inhibitory pathways hiv antigens. ftr may help to
individualize immunomodulation warrants assessment clinical
immunotherapy trials.

doi: 10.1371/journal.pone.0153849 
pmcid: pmc4851414
pmid: 27128502  [indexed medline]

